308 related articles for article (PubMed ID: 27571928)
1. Amino Acid Metabolism Abnormity and Microenvironment Variation Mediated Targeting and Controlled Glioma Chemotherapy.
An S; Lu X; Zhao W; Sun T; Zhang Y; Lu Y; Jiang C
Small; 2016 Oct; 12(40):5633-5645. PubMed ID: 27571928
[TBL] [Abstract][Full Text] [Related]
2. Asn-Gly-Arg-modified polydopamine-coated nanoparticles for dual-targeting therapy of brain glioma in rats.
Hu J; Zhang X; Wen Z; Tan Y; Huang N; Cheng S; Zheng H; Cheng Y
Oncotarget; 2016 Nov; 7(45):73681-73696. PubMed ID: 27655664
[TBL] [Abstract][Full Text] [Related]
3. ATP/pH Dual Responsive Nanoparticle with d-[des-Arg
Zhang Y; Lu Y; Wang F; An S; Zhang Y; Sun T; Zhu J; Jiang C
Small; 2017 Jan; 13(3):. PubMed ID: 27775872
[TBL] [Abstract][Full Text] [Related]
4. Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes.
Gao JQ; Lv Q; Li LM; Tang XJ; Li FZ; Hu YL; Han M
Biomaterials; 2013 Jul; 34(22):5628-39. PubMed ID: 23628475
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles.
Ruan S; Yuan M; Zhang L; Hu G; Chen J; Cun X; Zhang Q; Yang Y; He Q; Gao H
Biomaterials; 2015 Jan; 37():425-35. PubMed ID: 25453970
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity.
Zhao Y; Ren W; Zhong T; Zhang S; Huang D; Guo Y; Yao X; Wang C; Zhang WQ; Zhang X; Zhang Q
J Control Release; 2016 Jan; 222():56-66. PubMed ID: 26682502
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors.
Byeon HJ; Thao le Q; Lee S; Min SY; Lee ES; Shin BS; Choi HG; Youn YS
J Control Release; 2016 Mar; 225():301-13. PubMed ID: 26826308
[TBL] [Abstract][Full Text] [Related]
8. Large amino acid transporter 1 mediated glutamate modified docetaxel-loaded liposomes for glioma targeting.
Li L; Di X; Zhang S; Kan Q; Liu H; Lu T; Wang Y; Fu Q; Sun J; He Z
Colloids Surf B Biointerfaces; 2016 May; 141():260-267. PubMed ID: 26859117
[TBL] [Abstract][Full Text] [Related]
9. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
[TBL] [Abstract][Full Text] [Related]
10. Choline transporter-targeting and co-delivery system for glioma therapy.
Li J; Guo Y; Kuang Y; An S; Ma H; Jiang C
Biomaterials; 2013 Dec; 34(36):9142-8. PubMed ID: 23993342
[TBL] [Abstract][Full Text] [Related]
11. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes.
Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT
Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650
[TBL] [Abstract][Full Text] [Related]
12. Primary M1 macrophages as multifunctional carrier combined with PLGA nanoparticle delivering anticancer drug for efficient glioma therapy.
Pang L; Zhu Y; Qin J; Zhao W; Wang J
Drug Deliv; 2018 Nov; 25(1):1922-1931. PubMed ID: 30465444
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
14. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
[TBL] [Abstract][Full Text] [Related]
15. Cell-permeable NF-κB inhibitor-conjugated liposomes for treatment of glioma.
Zhang Y; Zhang L; Hu Y; Jiang K; Li Z; Lin YZ; Wei G; Lu W
J Control Release; 2018 Nov; 289():102-113. PubMed ID: 30243823
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles.
Wang L; Hao Y; Li H; Zhao Y; Meng D; Li D; Shi J; Zhang H; Zhang Z; Zhang Y
J Drug Target; 2015; 23(9):832-46. PubMed ID: 25856302
[TBL] [Abstract][Full Text] [Related]
17. Dual Functional Peptide-Driven Nanoparticles for Highly Efficient Glioma-Targeting and Drug Codelivery.
Kuang Y; Jiang X; Zhang Y; Lu Y; Ma H; Guo Y; Zhang Y; An S; Li J; Liu L; Wu Y; Liang J; Jiang C
Mol Pharm; 2016 May; 13(5):1599-607. PubMed ID: 27058780
[TBL] [Abstract][Full Text] [Related]
18. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.
Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y
Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677
[TBL] [Abstract][Full Text] [Related]
19. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.
Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X
Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009
[TBL] [Abstract][Full Text] [Related]
20. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.
Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X
J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
